SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the appointment of Wei Wei Chen to the company’s Board of Directors. “I am pleased to welcome Wei […]
Author: Ken Dropiewski
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated technology […]
Gradient Denervation Technologies Announces Appointment of Martin Grasse as Chief Executive Officer
PARIS, FRANCE / ACCESSWIRE / April 7, 2022 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive solution for the treatment of heart failure patients with pulmonary hypertension, announced today the appointment of Martin Grasse as Chief Executive Officer. With over 15 years in the medical device industry, […]
Karoo Health Receives Seed Funding from Panoramic Ventures and FirstMile Ventures to Reimagine Cardiovascular Care
Investment to Support Company’s Engagement with Health Plans and Self-Insured Employers to Provide Tech-Enabled Value-Based Cardiology Solutions AUSTIN, Texas and ALBUQUERQUE, N.M., April 6, 2022 /PRNewswire/ — Karoo Health, a leader in tech-enabled value-based cardiovascular care solutions, today announced it closed a significant seed funding round. The investment will allow Karoo Health to bring its […]
CathWorks and Quest International Announce Global Post-Sales Technical Service Support Partnership
KFAR-SABA, Israel and IRVINE, Calif., April 6, 2022 /PRNewswire/ — CathWorks, an original equipment manufacturer (OEM), and Quest International, a global service support provider to the OEMs, announced today they have signed a post-sales technical service support agreement that Quest International becomes the preferred technical service delivery partner for end-to-end service support of CathWorks’ fast-growing […]
New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure
Study Presented at the 71st Annual American College of Cardiology Meeting Oak Ridge, TN, April 06, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces new data from Duke Heart that was presented on April 2nd at the American College of Cardiology (ACC) 71st Scientific Sessions […]
Flow Therapy Adds World-Renowned Cardiologist Timothy D. Henry to Board of Directors
FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) — World-renowned cardiologist Timothy D. Henry, MD, FACC, MSCAI, has joined Flow Therapy’s Board of Directors. Dr. Henry is the Lindner Family Distinguished Chair in Clinical Research and Medical Director of The Carl and Edyth Lindner Center for Research at The Christ Hospital […]
Cardior Appoints Dr. Russell Greig as Independent Chairman of the Board
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr. Russell Greig, as independent Chairman of its Board of Directors. Dr. Greig brings more than 35 years of experience in the pharmaceutical industry from GlaxoSmithKline, with […]
United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation
In subjects with PAH, transition from Tyvaso® to Tyvaso DPI™ demonstrated safety and tolerability with significant improvements in six-minute walk distance, device preference and satisfaction, and patient reported outcomes Tyvaso DPI safety confirmed through 51 weeks of optional extension phase data with no study drug-related serious adverse events FDA action on […]
RapidAI Announces Amit Phadnis as New Chief Innovation and Technology Officer
Former GE Healthcare Chief Digital Officer joins group of new leaders spearheading RapidAI’s product innovation; advancing patient care for Pulmonary Embolism, Aneurysm and Stroke globally SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular imaging driving the next evolution of clinical decision making and patient workflow, today announced […]



